Literature DB >> 26377636

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification predicts occult lymph node metastasis in clinically mediastinal node-negative lung adenocarcinoma.

Yi-Chen Yeh1, Kyuichi Kadota2, Jun-ichi Nitadori3, Camelia S Sima4, Nabil P Rizk5, David R Jones5, William D Travis6, Prasad S Adusumilli7.   

Abstract

OBJECTIVES: We investigated the role of the 2011 International Association for the Study of Lung Cancer, American Thoracic Society, and European Respiratory Society (IASLC/ATS/ERS) classification in predicting occult lymph node metastasis in clinically mediastinal node-negative lung adenocarcinoma.
METHODS: We reviewed lung adenocarcinoma patients who had clinically N2-negative status, were evaluated by preoperative positron emission tomography combined with computed tomography (PET/CT) and had undergone lobectomy or pneumonectomy at Memorial Sloan Kettering Cancer Center (n = 297). Tumours were classified according to the 2011 IASLC/ATS/ERS classification. The associations between occult lymph node metastasis and clinicopathological variables were analysed using Fisher's exact test and logistic regression analysis.
RESULTS: Thirty-two (11%) cN0-1 patients had occult mediastinal lymph node metastasis (pN2) whereas 25% of cN1 patients had pN2 disease. Increased micropapillary pattern was associated with increased risk of pN2 disease (P = 0.001). On univariate analysis, high maximum standard uptake value of the primary tumour on PET/CT (P = 0.019) and the presence of micropapillary (P = 0.014) and solid pattern (P = 0.014) were associated with occult pN2 disease. On multivariable analysis, micropapillary pattern was positively associated with risk of pN2 disease (odds ratio = 3.41; 95% confidence intervals = 1.42-8.19; P = 0.006).
CONCLUSIONS: The presence of micropapillary pattern is an independent predictor of occult mediastinal lymph node metastasis. Our observations have potential therapeutic implications for management of early-stage lung adenocarcinoma.
© The Author 2015. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Early stage; Lung cancer; Metastasis; Micropapillary; Non-small cell lung cancer

Mesh:

Year:  2015        PMID: 26377636      PMCID: PMC4678972          DOI: 10.1093/ejcts/ezv316

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  24 in total

1.  A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L).

Authors:  Kenichi Nakamura; Hisashi Saji; Ryu Nakajima; Morihito Okada; Hisao Asamura; Taro Shibata; Shinichiro Nakamura; Hirohito Tada; Masahiro Tsuboi
Journal:  Jpn J Clin Oncol       Date:  2009-11-22       Impact factor: 3.019

2.  Location as an important predictor of lymph node involvement for pulmonary adenocarcinoma.

Authors:  Ara Ketchedjian; Benedict D T Daly; Hiran C Fernando; Lauren Florin; Curtis J Hunter; Donna M Morelli; Richard J Shemin
Journal:  J Thorac Cardiovasc Surg       Date:  2006-07-31       Impact factor: 5.209

3.  Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.

Authors:  Sung Shine Shim; Kyung Soo Lee; Byung-Tae Kim; Myung Jin Chung; Eun Jung Lee; Joungho Han; Joon Young Choi; O Jung Kwon; Young Mog Shim; Seonwoo Kim
Journal:  Radiology       Date:  2005-07-12       Impact factor: 11.105

4.  Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images.

Authors:  Hiroaki Nomori; Kenichi Watanabe; Takashi Ohtsuka; Tsuguo Naruke; Keiichi Suemasu; Kimiichi Uno
Journal:  Lung Cancer       Date:  2004-07       Impact factor: 5.705

5.  Preoperative staging of lung cancer with combined PET-CT.

Authors:  Barbara Fischer; Ulrik Lassen; Jann Mortensen; Søren Larsen; Annika Loft; Anne Bertelsen; Jesper Ravn; Paul Clementsen; Asbjørn Høgholm; Klaus Larsen; Torben Rasmussen; Susanne Keiding; Asger Dirksen; Oke Gerke; Birgit Skov; Ida Steffensen; Hanne Hansen; Peter Vilmann; Grete Jacobsen; Vibeke Backer; Niels Maltbaek; Jesper Pedersen; Henrik Madsen; Henrik Nielsen; Liselotte Højgaard
Journal:  N Engl J Med       Date:  2009-07-02       Impact factor: 91.245

6.  A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.

Authors:  R Rosell; J Gómez-Codina; C Camps; J Maestre; J Padille; A Cantó; J L Mate; S Li; J Roig; A Olazábal
Journal:  N Engl J Med       Date:  1994-01-20       Impact factor: 91.245

7.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.

Authors:  Didier Lardinois; Walter Weder; Thomas F Hany; Ehab M Kamel; Stephan Korom; Burkhardt Seifert; Gustav K von Schulthess; Hans C Steinert
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

8.  Histopathological features and prognostic significance of the micropapillary pattern in lung adenocarcinoma.

Authors:  Kazunori Kamiya; Yuichiro Hayashi; Junya Douguchi; Akinori Hashiguchi; Taketo Yamada; Yotaro Izumi; Masazumi Watanabe; Masafumi Kawamura; Hirohisa Horinouchi; Naoki Shimada; Koichi Kobayashi; Michiie Sakamoto
Journal:  Mod Pathol       Date:  2008-05-30       Impact factor: 7.842

9.  Using frozen section to identify histological patterns in stage I lung adenocarcinoma of ≤ 3 cm: accuracy and interobserver agreement.

Authors:  Yi-Chen Yeh; Jun-ichi Nitadori; Kyuichi Kadota; Akihiko Yoshizawa; Natasha Rekhtman; Andre L Moreira; Camelia S Sima; Valerie W Rusch; Prasad S Adusumilli; William D Travis
Journal:  Histopathology       Date:  2015-02-05       Impact factor: 5.087

10.  Bronchioloalveolar carcinoma (lepidic growth) component is a more useful prognostic factor than lymph node metastasis.

Authors:  Yoichi Anami; Tatsuo Iijima; Kenji Suzuki; Jun Yokota; Yuko Minami; Hiromi Kobayashi; Kaishi Satomi; Yoshimasa Nakazato; Masafumi Okada; Masayuki Noguchi
Journal:  J Thorac Oncol       Date:  2009-08       Impact factor: 15.609

View more
  18 in total

1.  Histologic subtype component predicts lymph node micrometastasis and prognosis in patients with stage I lung adenocarcinoma.

Authors:  Jung-Jyh Hung
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

2.  Predictors of recurrence and survival of pathological T1N0M0 invasive adenocarcinoma following lobectomy.

Authors:  Yiyang Wang; Difan Zheng; Jiajie Zheng; Qingyuan Huang; Baohui Han; Jie Zhang; Heng Zhao; Haiquan Chen
Journal:  J Cancer Res Clin Oncol       Date:  2018-03-12       Impact factor: 4.553

3.  Histologic Subtype in Core Lung Biopsies of Early-Stage Lung Adenocarcinoma is a Prognostic Factor for Treatment Response and Failure Patterns After Stereotactic Body Radiation Therapy.

Authors:  Jonathan E Leeman; Andreas Rimner; Joseph Montecalvo; Meier Hsu; Zhigang Zhang; Donata von Reibnitz; Kelly Panchoo; Ellen Yorke; Prasad S Adusumilli; William Travis; Abraham J Wu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-09-29       Impact factor: 7.038

4.  Computed tomography radiomics-based distinction of invasive adenocarcinoma from minimally invasive adenocarcinoma manifesting as pure ground-glass nodules with bubble-like signs.

Authors:  Yining Jiang; Ziqi Xiong; Wenjing Zhao; Jingyu Zhang; Yan Guo; Guosheng Li; Zhiyong Li
Journal:  Gen Thorac Cardiovasc Surg       Date:  2022-03-18

5.  Multimodality therapy in subclassified stage IIIA-N2 non-small cell lung cancer patients according to the Robinson classification: heterogeneity and management.

Authors:  Hans-Stefan Hofmann; Jan Braess; Susanne Leipelt; Michael Allgäuer; Monika Klinkhammer-Schalke; Tamas Szoeke; Christian Grosser; Michael Pfeifer; Michael Ried
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

6.  Targeted Sequencing Analysis of Predominant Histological Subtypes in Resected Stage I Invasive Lung Adenocarcinoma.

Authors:  Yan Li; Yan Tan; Song Hu; Jun Xie; Zhantao Yan; Xian Zhang; Yun Zong; Han Han-Zhang; Qing Li; Chong Li
Journal:  J Cancer       Date:  2021-04-02       Impact factor: 4.207

7.  Application of Artificial Neural Network to Preoperative 18F-FDG PET/CT for Predicting Pathological Nodal Involvement in Non-small-cell Lung Cancer Patients.

Authors:  Silvia Taralli; Valentina Scolozzi; Luca Boldrini; Jacopo Lenkowicz; Armando Pelliccioni; Margherita Lorusso; Ola Attieh; Sara Ricciardi; Francesco Carleo; Giuseppe Cardillo; Maria Lucia Calcagni
Journal:  Front Med (Lausanne)       Date:  2021-04-22

8.  Expansion of the Concept of Micropapillary Adenocarcinoma to Include a Newly Recognized Filigree Pattern as Well as the Classical Pattern Based on 1468 Stage I Lung Adenocarcinomas.

Authors:  Katsura Emoto; Takashi Eguchi; Kay See Tan; Yusuke Takahashi; Rania G Aly; Natasha Rekhtman; William D Travis; Prasad S Adusumilli
Journal:  J Thorac Oncol       Date:  2019-07-25       Impact factor: 15.609

9.  Preoperative clinical and tumor genomic features associated with pathologic lymph node metastasis in clinical stage I and II lung adenocarcinoma.

Authors:  Raul Caso; James G Connolly; Jian Zhou; Kay See Tan; James J Choi; Gregory D Jones; Brooke Mastrogiacomo; Francisco Sanchez-Vega; Bastien Nguyen; Gaetano Rocco; Daniela Molena; Smita Sihag; Prasad S Adusumilli; Matthew J Bott; David R Jones
Journal:  NPJ Precis Oncol       Date:  2021-07-21

10.  Minor Components of Micropapillary and Solid Subtypes in Lung Adenocarcinoma are Predictors of Lymph Node Metastasis and Poor Prognosis.

Authors:  Yue Zhao; Rui Wang; Xuxia Shen; Yunjian Pan; Chao Cheng; Yuan Li; Lei Shen; Yang Zhang; Hang Li; Difan Zheng; Ting Ye; Shanbo Zheng; Yihua Sun; Haiquan Chen
Journal:  Ann Surg Oncol       Date:  2016-02-02       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.